Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.65
+0.03 (0.22%)
At close: Aug 11, 2026, 4:00 PM EDT
13.65
0.00 (0.00%)
Pre-market: Aug 12, 2026, 7:38 AM EDT
Organon & Co. Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,132 | 574 | 675 | 693 | 706 | 737 |
Cash & Short-Term Investments | 1,132 | 574 | 675 | 693 | 706 | 737 |
Cash Growth | 88.98% | -14.96% | -2.60% | -1.84% | -4.21% | 6041.67% |
Accounts Receivable | 1,492 | 1,331 | 1,358 | 1,744 | 1,475 | 1,382 |
Inventory | 1,351 | 1,406 | 1,321 | 1,315 | 1,003 | 915 |
Other Current Assets | 1,136 | 1,041 | 994 | 756 | 747 | 726 |
Total Current Assets | 5,111 | 4,352 | 4,348 | 4,508 | 3,931 | 3,760 |
Net Property, Plant & Equipment | 1,281 | 1,303 | 1,168 | 1,183 | 1,018 | 973 |
Other Intangible Assets | 1,112 | 1,130 | 1,414 | 533 | 649 | 651 |
Goodwill | 4,153 | 4,153 | 4,680 | 4,603 | 4,603 | 4,603 |
Other Long-Term Assets | 1,521 | 1,929 | 1,491 | 1,231 | 754 | 694 |
Total Assets | 13,178 | 12,867 | 13,101 | 12,058 | 10,955 | 10,681 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,051 | 952 | 1,153 | 1,314 | 1,132 | 1,382 |
Accrued Expenses | 1,407 | 1,335 | 1,411 | 1,389 | 1,188 | 1,021 |
Current Portion of Long-Term Debt | 74 | 16 | 20 | 9 | 8 | 9 |
Other Current Liabilities | 84 | 87 | 134 | 206 | 184 | 185 |
Total Current Liabilities | 2,616 | 2,390 | 2,718 | 2,918 | 2,512 | 2,597 |
Long-Term Debt | 8,479 | 8,628 | 8,860 | 8,751 | 8,905 | 9,125 |
Other Long-Term Liabilities | 1,077 | 1,097 | 1,051 | 459 | 430 | 467 |
Total Long-Term Liabilities | 9,556 | 9,725 | 9,911 | 9,210 | 9,335 | 9,592 |
Total Liabilities | 12,172 | 12,115 | 12,629 | 12,128 | 11,847 | 12,189 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3 | 3 | 3 | 3 | 3 | 3 |
Additional Paid-in Capital | 199 | 167 | 108 | 25 | - | - |
Accumulated Other Comprehensive Income | -548 | -527 | -649 | -541 | -564 | -513 |
Retained Earnings | 1,352 | 1,109 | 1,010 | 443 | -331 | -998 |
Shareholders' Equity | 1,006 | 752 | 472 | -70 | -892 | -1,508 |
Total Liabilities & Equity | 13,178 | 12,867 | 13,101 | 12,058 | 10,955 | 10,681 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8,553 | 8,644 | 8,880 | 8,760 | 8,913 | 9,134 |
Net Cash (Debt) | -7,421 | -8,070 | -8,205 | -8,067 | -8,207 | -8,397 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -28.16 | -30.95 | -31.66 | -31.48 | -32.16 | -33.03 |
Book Value | 1,006 | 752 | 472 | -70 | -892 | -1,508 |
Book Value Per Share | 3.82 | 2.88 | 1.82 | -0.27 | -3.50 | -5.93 |
Tangible Book Value | -4,259 | -4,531 | -5,622 | -5,206 | -6,144 | -6,762 |
Tangible Book Value Per Share | -16.16 | -17.38 | -21.69 | -20.31 | -24.08 | -26.60 |